Study supports evidence that ivermectin is ineffective at treating COVID-19

High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford affiliated researchers in a study published today in eLife. A new study from researchers at the University of Oxford has revealed that high doses of the drug ivermectin are not effective at treating the COVID-19 virus. The findings, published today in the journal eLife, put an end to the controversial practice of using the drug to treat the virus, which has been advocated by some high-profile political and media figures. The study, which was led by Dr. Michael Davies from the University of Oxford, used a combination of in vitro and in vivo testing to study the effects of ivermectin on the coronavirus. In vitro testing involves testing the drug on cultures of cells, while in vivo tests are conducted on animals. The researchers found that ivermectin was not effective at reducing the replication of SARS-CoV-2, the virus that causes COVID-19, in either cultured cells or animal models. Furthermore, they found that the drug caused a reduction in the activity of the protein known as the 'inflammasome', which is important for immune function. This could potentially increase the risk of severe inflammation. The study authors concluded that while ivermectin may have a positive effect on other viruses, it is not effective against the SARS-CoV-2 virus that causes COVID-19, and thus not a viable treatment for the disease. The controversial practice of using high doses of ivermectin to treat COVID-19 has been advocated by some high-profile political and media figures. Despite the lack of conclusive scientific evidence, some have argued that ivermectin could be used as a treatment for the virus. This new research suggests otherwise, providing concrete scientific evidence that ivermectin is not effective at treating the coronavirus. The authors of the study hope their findings will put an end to the misleading and potentially dangerous practice of using ivermectin to treat COVID-19. They warn that such practices may only further complicate treatment of the virus, and could even put patients at risk of further complications. The findings of the study are clear – high doses of ivermectin are not effective at treating the COVID-19 virus. This new research serves as an important reminder to follow the advice of medical professionals, and to avoid unproven treatments, particularly when it comes to possible treatments for COVID-19. With the emergence of the COVID-19 pandemic, the need for effective treatments has become increasingly apparent. As such, it is essential that we rely on evidence-based science to inform our decisions, and avoid potentially dangerous practices. This latest research from the University of Oxford highlights the importance of relying on scientific evidence, rather than the opinions of high-profile figures, when it comes to our health. It is clear that high doses of ivermectin are not effective at treating the coronavirus. This research underscores the importance of relying on scientific evidence when it comes to making healthcare decisions, particularly during the COVID-19 pandemic. This new study is a positive step towards understanding the virus, and provides important information that may help to inform future treatments.

https://www.lifetechnology.com/blogs/life-technology-medical-news/study-supports-evidence-that-ivermectin-is-ineffective-at-treating-covid-19

Buy SuperforceX™